Masaaki Hirano

2.5k total citations
63 papers, 1.3k citations indexed

About

Masaaki Hirano is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Masaaki Hirano has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Masaaki Hirano's work include Pharmacy and Medical Practices (8 papers), Fibroblast Growth Factor Research (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Masaaki Hirano is often cited by papers focused on Pharmacy and Medical Practices (8 papers), Fibroblast Growth Factor Research (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Masaaki Hirano collaborates with scholars based in Japan, United States and Australia. Masaaki Hirano's co-authors include Atsushi Nakajima, Koji Kaya, Ken Judai, Masanori Okamoto, Ikuo Miura, Nozomi Niitsu, Tsuyoshi Kurikawa, Satoshi Nagao, Hiroaki Takeda and Yasuyuki Endo and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Masaaki Hirano

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masaaki Hirano Japan	18	286	246	226	194	176	63	1.3k
Masayuki Kobayashi Japan	28	726 2.5×	136 0.6×	335 1.5×	217 1.1×	333 1.9×	145	2.7k
Bart de Vries Netherlands	32	649 2.3×	94 0.4×	90 0.4×	148 0.8×	253 1.4×	86	3.3k
Y. Inada Japan	33	703 2.5×	243 1.0×	115 0.5×	345 1.8×	68 0.4×	196	3.7k
Hiroshi Yasuhara Japan	24	129 0.5×	744 3.0×	119 0.5×	164 0.8×	81 0.5×	157	2.3k
Mamoru Yamashita Japan	22	515 1.8×	148 0.6×	125 0.6×	237 1.2×	339 1.9×	151	2.0k
Huijun Zhou China	24	500 1.7×	97 0.4×	115 0.5×	127 0.7×	268 1.5×	121	1.8k
Koji Ogata Japan	26	1.2k 4.2×	130 0.5×	147 0.7×	199 1.0×	136 0.8×	84	2.7k
Tetsuya Inoue Japan	23	211 0.7×	97 0.4×	390 1.7×	90 0.5×	228 1.3×	131	1.8k
Jun Zeng China	29	885 3.1×	337 1.4×	278 1.2×	149 0.8×	383 2.2×	127	2.3k
Matthias Pfeiffer Germany	37	1.0k 3.6×	515 2.1×	502 2.2×	311 1.6×	635 3.6×	142	4.3k

Countries citing papers authored by Masaaki Hirano

Since Specialization

Citations

This map shows the geographic impact of Masaaki Hirano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Hirano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Hirano more than expected).

Fields of papers citing papers by Masaaki Hirano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Hirano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Hirano. The network helps show where Masaaki Hirano may publish in the future.

Co-authorship network of co-authors of Masaaki Hirano

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Hirano. A scholar is included among the top collaborators of Masaaki Hirano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Hirano. Masaaki Hirano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kameda, Minoru, Yuichiro Kawamoto, Hiroyuki Moritomo, et al.. (2022). Discovery of ASP5878: Synthesis and structure–activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity. Bioorganic & Medicinal Chemistry. 59. 116657–116657. 8 indexed citations

Kameda, Minoru, Yuichiro Kawamoto, Hiroyuki Moritomo, et al.. (2021). Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. Bioorganic & Medicinal Chemistry. 33. 116019–116019. 9 indexed citations

Tanaka, Hiroaki, Hideki Sakagami, Naoki Kaneko, et al.. (2019). Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression. Molecular Cancer Therapeutics. 18(8). 1366–1373. 15 indexed citations

Hirano, Masaaki, et al.. (2019). Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4<i>H</i>-pyrido[3,2-<i>e</i>][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists. Chemical and Pharmaceutical Bulletin. 67(7). 699–706. 4 indexed citations

Yamada, Shinya, Waku Hatta, Tooru Shimosegawa, et al.. (2018). Different risk factors between early and late cancer recurrences in patients without additional surgery after noncurative endoscopic submucosal dissection for early gastric cancer. Gastrointestinal Endoscopy. 89(5). 950–960. 22 indexed citations

Futami, T., Hidetsugu Okada, Rumi Kihara, et al.. (2016). ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 16(1). 68–75. 34 indexed citations

Futami, T., Hidetsugu Okada, Rumi Kihara, et al.. (2015). Abstract A172: Preclinical antitumor activity of ASP5878, a novel inhibitor of FGFR1, 2, 3 and 4, in FGF19-expressing hepatocellular carcinoma. Molecular Cancer Therapeutics. 14(12_Supplement_2). A172–A172. 1 indexed citations

Hirano, Masaaki. (2014). Ultra-low loss fiber for practicable trans-oceanic high capacity transmission. Australian Conference on Optical Fibre Technology. 383. 1 indexed citations

Hirano, Masaaki, et al.. (2012). Development of team-based care as a result of the introduction of a regional cooperative clinical path sheet in interferon treatment for chronic hepatitis C. Kanzo. 53(5). 263–271.

10.

Ise, Yuya, Ayumi Kato, Kenji Nishizawa, et al.. (2005). Assessment of Quality of Life for Cancer Patients in Field of Palliative Care-Evaluation of the Use of Japanese Version of EQ-5D Health Related Quality of Life Questionnaire. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(9). 768–776. 2 indexed citations

11.

Matsumoto, Yoshiaki, et al.. (2005). Pharmacokinetics of Midazolam in Critically Ill Patients Receiving Continuous Hemodiafiltration using a Polymethyl Methacrylate and/or Polysulfone Membrane. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(2). 99–104. 2 indexed citations

12.

Ise, Yuya, et al.. (2005). Preparation of a Care Work Sheet for Liver Cirrhosis Patients and Medication Management for Them by Tokyo Hospital Pharmacists Association. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(8). 668–678.

13.

Ise, Yuya, et al.. (2003). The Analysis of Prescription Frequency and the Factors on Adverse Reactions of NSAIDs for Post-Operative Pain in Orthopedic Patients. YAKUGAKU ZASSHI. 123(7). 613–618. 5 indexed citations

14.

Ise, Yuya, et al.. (2003). Pharmacoeconomical Efficacy of Critical Pathways Instructions for Medication Management and Instruction Tasks for Gastrectomy Patients.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29(1). 28–32. 2 indexed citations

15.

Koinuma, Masayoshi, et al.. (2003). The Influence of Oil-Based Ink Containing Xylene for Plastic Containers Used in Making Infusions. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29(2). 203–209. 1 indexed citations

16.

Hirano, Masaaki, Shuichi Kaneko, Tatsuya Yamashita, et al.. (2003). Direct Interaction between Nucleolin and Hepatitis C Virus NS5B. Journal of Biological Chemistry. 278(7). 5109–5115. 55 indexed citations

17.

Ise, Yuya, et al.. (2002). Cost-Effective Analysis of Prophylactic Antibiotic Therapy between Flomoxef and Cefmetazole in Colorectal Cancer Surgery.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(1). 47–50. 1 indexed citations

18.

Tanabe, Taishi, Masaaki Hirano, Kazuhiko Hirose, et al.. (1996). Correlation between occurrence of exudative epidermitis and exfoliative toxin-producing ability of Staphylococcus hyicus. Veterinary Microbiology. 48(1-2). 9–17. 45 indexed citations

19.

Kitamura, K, et al.. (1988). Sensitivity and accuracy in recording his-purkinje activity by surface-averaged electrocardiography. Journal of Electrocardiology. 21(1). 65–70. 2 indexed citations

20.

Hirano, Masaaki, et al.. (1984). <title>Present Status Of Local Area Network Systems Using Optical Fibers In Japan</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 403. 71–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact